Screener

This page is a wide table. It works on a phone - the table scrolls sideways - but a laptop or a desktop shows many more columns at once.

Add columns 9 of 30

Click a figure to put it on the table; click a lit one to take it off again. Every column carries its own filters under its heading, and the arrows there move it left or right.

Company What the company is, where it trades, and how current our figures for it are.

Size & market How big it is and what the share price has done. Everything here needs a price.

Valuation What the market charges for a dollar of earnings, sales, book value or cash flow.

Profitability What share of revenue it keeps, and what it earns on the capital it uses.

Growth Change against the year before, and three-year compound rates.

Financial health Borrowings measured against the earnings, equity and assets that have to cover them.

Per share The same figures divided by the share count.

Income statement Amounts as reported on the income statement, latest full year.

Cash flow Amounts as reported on the cash flow statement, latest full year.

Balance sheet Amounts as reported on the balance sheet, at the latest year end.

Saved screens 0

Save the screener settings in the browser.

    Width
    Rows
    Reset all
    Filtering on Sector: Healthcare (remove)

    1,064 companies - showing 526-550

    Ticker
    Company
    × › ↺ Our own rollup of SEC's SIC code, not GICS. See About the data.
    Sector
    ‹ × › Amounts take a suffix: 2B, 500M, 1.5T, 250K.
    Market cap
    ‹ × ›
    P/E
    ‹ × ›
    EV/EBITDA
    ‹ × › In percent: type 15 for 15%.
    Dividend yield
    ‹ × › In percent: type 15 for 15%.
    EPS growth
    ‹ × › In percent: type 15 for 15%.
    ROIC
    ‹ × › In percent: type 15 for 15%.
    ROE
    ‹ ×
    Net debt / EBITDA
    CYPH CYPHERPUNK TECHNOLOGIES INC. Healthcare $260.8M 34.6x — — — — 3.3% —
    PROF Profound Medical Corp. Healthcare $251.7M 4.9x — — 25.9% -45.9% -64.1% —
    NAGE Niagen Bioscience, Inc. Healthcare $250.8M 15.8x 14.8x — 81.8% — 22.7% —
    LIMN Liminatus Pharma, Inc. Healthcare $249.2M — — — — — — —
    NATR NATURES SUNSHINE PRODUCTS INC Healthcare $246.7M 13.2x 6.4x — 165.0% — 12.1% —
    NMRA Neumora Therapeutics, Inc. Healthcare $246.1M — — — — -87.2% 228.1% —
    ELDN Eledon Pharmaceuticals, Inc. Healthcare $245.4M — — — — — -56.3% —
    INFU InfuSystem Holdings, Inc Healthcare $243.8M 39.5x 10.7x — 181.8% 9.7% 11.6% 0.68
    IVVD Invivyd, Inc. Healthcare $243.5M — — — — — -21.7% —
    OSUR ORASURE TECHNOLOGIES INC Healthcare $240.0M — — — — — -20.2% —
    SIGA SIGA TECHNOLOGIES INC Healthcare $236.4M 10.3x 9.7x 18.2% -61.0% — 11.7% —
    LODE Comstock Inc. Healthcare $236.3M — — — — -35.5% -40.1% —
    PDEX PRO DEX INC Healthcare $235.2M 17.8x 16.9x — 54.3% 15.1% 28.7% 0.57
    ELMD Electromed, Inc. Healthcare $234.3M 21.5x 15.9x — 52.9% — 20.9% —
    GLSI Greenwich LifeSciences, Inc. Healthcare $234.1M — — — — — -5,480.5% —
    TARA Protara Therapeutics, Inc. Healthcare $232.8M — — — — — -29.2% —
    FF FutureFuel Corp. Healthcare $230.7M — — 4.6% -422.9% — -31.9% —
    ABOS Acumen Pharmaceuticals, Inc. Healthcare $230.0M — — — — -96.3% -172.3% —
    UTMD UTAH MEDICAL PRODUCTS INC Healthcare $226.4M 20.4x 11.5x 1.8% -12.1% 7.6% 9.5% -7.01
    TNXP Tonix Pharmaceuticals Holding Corp. Healthcare $225.4M — — — — — -50.6% —
    KROS Keros Therapeutics, Inc. Healthcare $224.4M 4.9x 3.2x — — — 28.7% —
    ANTX AN2 Therapeutics, Inc. Healthcare $222.3M — — — — — -66.3% —
    ORGO Organogenesis Holdings Inc. Healthcare $220.0M 11.4x 3.7x — — — 12.3% —
    STIM Neuronetics, Inc. Healthcare $219.4M — — — — -28.2% -174.3% —
    CHRS Coherus Oncology, Inc. Healthcare $219.4M 1.0x — — 472.0% — 275.4% —